Medications

Q&A: Experts discuss pros, cons of new Alzheimer's drug

Patient care teams are preparing to offer lecanemab, a new Alzheimer's disease treatment expected to soon receive approval from the U.S. Food and Drug Administration (FDA), to patients in the coming months.

Diseases, Conditions, Syndromes

Nearly half of Biden's 500M free COVID tests still unclaimed

Nearly half of the 500 million free COVID-19 tests the Biden administration recently made available to the public still have not been claimed as virus cases plummet and people feel less urgency to test.

Health

Medicare opens up access to free at-home COVID-19 tests

The Biden administration, seeking to fill a frustrating gap in coverage for COVID-19 tests, Thursday announced that people with Medicare will be able to get free over-the-counter tests much more easily in the coming weeks.

Diseases, Conditions, Syndromes

Shortage of COVID-19 testing hurts efforts to fight 2nd wave

A shortage of COVID-19 testing in the U.K. is jeopardizing efforts to restore medical services and prepare for a potential surge in coronavirus cases this winter, the group that represents hospitals in England said Tuesday.

Health

Clinical guidelines from specialty societies often biased

Clinical practice guidelines issued by specialty societies in North America often recommend health care services linked to their specialties, in contrast with European guidelines and those from independent organizations, ...

page 8 from 9